Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NantKwest launches phase 1 trial with targeted PD-L1 t-haNK cell therapy in patients with solid tumors
Image: NantKwest launches phase 1 trial with targeted PD-L1 t-haNK cell therapy in patients with solid tumors. Photo: courtesy of skeeze from Pixabay.